Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company Contraline Closes $10.7 Million Series A Financing to Become a Clinical Stage Company
HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout HemoShear Therapeutics Advances Second Novel Drug Target into Horizon Therapeutics plc Early Discovery Pipeline for Gout
